The aim of this study is to further investigate the correlation between Site and size of adenoid hypertrophy and middle ear effusion in order to provide evidence for designing a more standardized approach to the diagnosis and treatment of OME.
Children (until age of 16 years old).
Patients with adenoid hypertrophy.
Patients with OME.
Children known to have cleft palate, submucous cleft palate or other medical problems causing velopharyngeal insufficiency.
Down's syndrome, septal deviation, primary ciliary dyskinesia (Kartagener's syndrome), previous head or ear trauma, or previous myringotomy with ventilation tube insertion
Systemic medical problems interfering with surgery.
Refusal of parents to participate.
Children age group (from 1 year old till 16 years old), male and female are included, with symptoms and signs of adenoid hypertrophy
Cohort
Prospective
Not listed
Comparing presence of middle ear effusion in relation to site and size of adenoid hypertrophy
The incidence of OME with each AH grade occurring in each age group of the sample size.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
